The Zletovo is lead–zinc (Pb–Zn) deposit, adjacent to the Plavica volcanic centre (R. Macedonia) with high-sulphidation and porphyry mineralisation. The analysis of fluid inclusions showed homogenisation temperatures in the range 335–145°C, which reflects phases of pulsation of hydrothermal solutions and defined into four groups from the lowest to the highest temperatures. The frequency of the homogenisation temperatures ranged from 265 to 125°C and with the most dominant from 245 to 225°C, from 225 to 205°C and from 145 to 125°C. Also, it was confirmed that hydrothermal ore-bearing solutions were defined as NaCl-type with range from 4.4 to 8.6 wt% NaCl equivalent. The latest stage salinities ranged from 3 to 12 wt% NaCl equivalent, where those from 10 to 12 wt% and from 6 to 8 wt% NaCl equivalent, prevailed. This suggests that hydrothermal solutions within analysed quartz grains were at final mineralizing phase. Density of fluid inclusions ranged from 0.7 to 0.95g/cm3. Calculated pressures and paleo-depths of mineralisation ranged from 14 to 130 bar and from 0.6 to 0.8 km.
Association Between Osteoarticular Scores and Acute Phase Reactant Levels in Rheumatoid Arthritis
The aim of this prospective control study was a quantitative evaluation of the activity of rheumatoid arthritis (RA) in certain time intervals, using articular indexes (set of 28 sensitive and 28 swollen joints), laboratory parameters (Hb, Hct, Er, Le and Plt) and acute phase reactants (ESR, RF, CRP); to determine which of the acute phase reactants is the most useful biochemical marker for the evaluation of disease activity in RA; to quantify the therapeutical and laboratory differences in certain time intervals in the group with and without immunomodulatory therapy with Methotrexate. Sixty patients with RA were included, 27 of who were treated with non-steroid antiinflammatory drugs (NSAIDs) and Methotrexate (MTX). The control group consisted of 33 patients treated only with NSAIDs because of irregular controls. In the first group of patients the disease activity was estimated at four time intervals, and in the control group of patients at three time intervals following the scores of the articular indexes, blood cell counts, ESR and CRP in every patient. In the first group of patients decreased activity of RA was found upon every following control with a consecutive decrease in mean values of the scores of articular indexes with statistically significant differences at the four time intervals. Considering laboratory parameters, there were statistically significant differences in the mean values of Hb, Er, Plt, ESR, (p=0.0462, p=0.0076, p= 0.0058, p= 0.0003). Mean values of CRP did not show statistically significant differences, but the number of patients who were CRP negative increased (there were great standard deviations). In the group of patients treated only with NSAIDs, there were statistically significant differences in the mean values of the scores of articular indexes with an increse at every following control (in favour of progression of the disease). There were no statistically significant differences considering blood cell counts, ESR and CRP (in favour of permanently active disease). In conclusion, CRP is the most useful marker for the prospective follow-up of patients with RA.